While these products are generally safe when used according to labeling, pharmacists must be familiar with available evidence in order to help patients safely self-medicate.
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.